Process and intermediates for the preparation of dasatinib
EP2878600A1
Stable complexes of an alkaline earth metal salt of N5-methyl-tetrahydrofolic acid and a polyol
EP2789611A1
A crystalline form of tiotropium bromide
HUE034540T2
Continuous process for the alkylation of cyclic tertiary amines
CH699426B1
Preparing calcium salt of (6S)-N(5)-methyl-5,6,7,8-tetrahydrofolic acid, comprises suspending crystalline (6S)-N(5)-methyl-5,6,7,8-tetrahydrofolic acid in water, adding sodium hydroxide and calcium chloride, precipitating and isolating
Process for regioselective N (5) -Formylierung of (6S) -5, 6, 7, 8-Tetrahydropteroinsäure and derivatives thereof.
CH696717A5
Concentrated, stable solution, in particular an injection solution or infusion solution, which Sodium folinate or (6S) Entholt -potassium folinate together with water either (6S)
ZA200202136B
A method for the production of pharmaceutically active recombinant proteins.
US6162914A
Process for the reduction of pterins
CH691538A5
Preparation of 5,6,7,8-tetrahydropterins from pterins using a lead salt catalyst to reduce the amount of borohydride reducing agent required, can be carried out at low temperatures
CH690103A5
Methylene-diphosphonic acid preparation in pharmaceutical purity, by relfuxing corresponding tetraalkyl ester with 3-6C alcohol
EP0757055A2
Glycosides, sugar-free degradation products and derivatives of the same
CH690075A5
Process for the preparation of 9,10-secocholesta-5, 7, 10 (19) -trienes by reduction of the epoxides.
EP0684231A1
Pharmaceutical preparation for modulating immunological reactions and new derivatives of indols and quinoline
CH689139A5
Process for the preparation of a liposomal, in water dispersable, orally administrable, solid, dry therapeutic formulation.
CH687062A5
Concentrated injection solution of alkali metal salts of reduced folates.
